Masimo Stock Today

MASI Stock  USD 130.15  2.81  2.11%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Masimo is trading at 130.15 as of the 15th of February 2026. This is a 2.11% down since the beginning of the trading day. The stock's open price was 132.96. Masimo has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Note, on October 16, 2025, Representative Kevin Hern of US Congress acquired $15k to $50k worth of Masimo's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
8th of August 2007
Category
Healthcare
Classification
Health Care
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company was incorporated in 1989 and is headquartered in Irvine, California. Masimo Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 53.71 M outstanding shares of which 4.11 M shares are now shorted by private and institutional investors with about 5.34 trading days to cover. More on Masimo

Moving against Masimo Stock

  0.56EDAP EDAP TMS SAPairCorr
  0.527D2A SEDANA MEDICAL ABPairCorr
  0.51DXCM DexCom IncPairCorr
  0.49EKSO Ekso Bionics HoldingsPairCorr
  0.41BLCO Bausch Lomb Corp Earnings Call This WeekPairCorr
  0.4ELMD Electromed Earnings Call This WeekPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Masimo Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Chairman OfficerSteven Barker
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP Midcap 400, NASDAQ Composite Total, NASDAQ Health Care, Obamacare Repeal, Baby Boomer Prospects, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.010.77
Significantly Up
Slightly volatile
Gross Profit Margin0.440.49
Moderately Down
Slightly volatile
Total Current Liabilities745.9 M710.4 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total1.2 B1.1 B
Sufficiently Up
Slightly volatile
Total Assets3.2 BB
Sufficiently Up
Slightly volatile
Total Current Assets1.5 B1.4 B
Sufficiently Up
Slightly volatile
Debt Levels
Debt leverage enables Masimo to amplify potential investment gains using borrowed funds. Evaluating debt relative to total assets helps investors assess Masimo's financial structure and understand the extent to which Masimo's operations depend on creditor capital.
Liquidity
Masimo currently holds 846.1 M in liabilities with Debt to Equity (D/E) ratio of 0.83, which is about average as compared to similar companies. Masimo has a current ratio of 2.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Masimo's use of debt, we should always consider it together with its cash and equity.

Change In Working Capital

(10.11 Million)
Masimo (MASI) is traded on NASDAQ Exchange in USA and employs 3,600 people. Masimo is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.99 B. Masimo conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 53.71 M outstanding shares of which 4.11 M shares are now shorted by private and institutional investors with about 5.34 trading days to cover. Masimo currently holds about 218 M in cash with 196.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.15.
Check Masimo Probability Of Bankruptcy
Ownership Allocation
The majority of Masimo outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Masimo to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Masimo. Please pay attention to any change in the institutional holdings of Masimo as this could imply that something significant has changed or is about to change at the company. On October 16, 2025, Representative Kevin Hern of US Congress acquired $15k to $50k worth of Masimo's common stock.
Check Masimo Ownership Details

Masimo Stock Institutional Holders

InstituionRecorded OnShares
Alyeska Investment Group, L.p.2025-06-30
1.1 M
Geode Capital Management, Llc2025-06-30
896.4 K
Alliancebernstein L.p.2025-06-30
844.1 K
Viking Global Investors Lp2025-06-30
767.4 K
Morgan Stanley - Brokerage Accounts2025-06-30
767.4 K
Liontrust Investment Partners Llp2025-06-30
708.3 K
Rtw Investments, Llc2025-06-30
683.3 K
Dimensional Fund Advisors, Inc.2025-06-30
523.2 K
Goldman Sachs Group Inc2025-06-30
471.5 K
Blackrock Inc2025-06-30
10.5 M
Fmr Inc2025-06-30
8.2 M
View Masimo Diagnostics

Masimo Historical Income Statement

As of now, Masimo's Gross Profit is increasing as compared to previous years. The Masimo's current Other Operating Expenses is estimated to increase to about 2.9 B, while Interest Expense is projected to decrease to under 43 M. View More Fundamentals

Masimo Stock Against Markets

Masimo Corporate Executives

Elected by the shareholders, the Masimo's board of directors comprises two types of representatives: Masimo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Masimo. The board's role is to monitor Masimo's management team and ensure that shareholders' interests are well served. Masimo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Masimo's outside directors are responsible for providing unbiased perspectives on the board's policies.
Micah CPAExecutive CFOProfile
When determining whether Masimo offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Masimo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Masimo Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Masimo Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Masimo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For more detail on how to invest in Masimo Stock please use our How to Invest in Masimo guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is there potential for Health Care Equipment & Supplies market expansion? Will Masimo introduce new products? Factors like these will boost the valuation of Masimo. Expected growth trajectory for Masimo significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Masimo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.144
Earnings Share
(4.56)
Revenue Per Share
40.426
Quarterly Revenue Growth
0.082
Return On Assets
0.0318
Investors evaluate Masimo using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Masimo's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Masimo's market price to deviate significantly from intrinsic value.
Understanding that Masimo's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Masimo represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Masimo's market price signifies the transaction level at which participants voluntarily complete trades.